Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruchit Sood

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|March 23, 2012
Should H pylori always be eradicated?Ruchit Sood
Gastroenterology|March 7, 2018
Histologic Criteria to Define Irritable Bowel Syndrome: Within the Realms of Possibility?Ruchit Sood, Alexander C Ford
Gastroenterology|October 27, 2015
Validation of a Serum Biomarker for Irritable Bowel Syndrome: Is an Accurate, Single Biomarker Test Possible?Ruchit Sood, Alexander C Ford
Gastroenterology|December 3, 2014
Central pain processing in irritable bowel syndrome is modulated by mood: a mechanism for the beneficial effects of antidepressants?Ruchit Sood, Alexander C Ford
Nature Reviews. Gastroenterology & Hepatology|July 14, 2016
Diagnosis: Rome IV criteria for FGIDs - an improvement or more of the same?Ruchit Sood, Alexander C Ford
Gastroenterology|March 27, 2014
Diagnosing irritable bowel syndrome with a combination of biomarkers and "psychomarkers"Ruchit Sood, Alexander C Ford
Therapeutic Advances in Chronic Disease|November 2, 2013
Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndromeRuchit Sood, Alexander C Ford
Clinical and Translational Gastroenterology|October 9, 2015
Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the PastRuchit Sood, Alexander C Ford
Gastroenterology|April 30, 2015
Combining biomarkers in irritable bowel syndrome: a forward step toward making a positive diagnosis and directing therapy?Ruchit Sood, Alexander C Ford
Gastroenterology|March 26, 2017
Derivation and Validation of a Panel of Exhaled Volatile Organic Compounds in Differentiating Irritable Bowel Syndrome From HealthRuchit Sood, Alexander C Ford
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|March 23, 2012
Should H pylori always be eradicated?Ruchit Sood
Gastroenterology|March 7, 2018
Histologic Criteria to Define Irritable Bowel Syndrome: Within the Realms of Possibility?Ruchit Sood, Alexander C Ford
Gastroenterology|October 27, 2015
Validation of a Serum Biomarker for Irritable Bowel Syndrome: Is an Accurate, Single Biomarker Test Possible?Ruchit Sood, Alexander C Ford
Gastroenterology|December 3, 2014
Central pain processing in irritable bowel syndrome is modulated by mood: a mechanism for the beneficial effects of antidepressants?Ruchit Sood, Alexander C Ford
Nature Reviews. Gastroenterology & Hepatology|July 14, 2016
Diagnosis: Rome IV criteria for FGIDs - an improvement or more of the same?Ruchit Sood, Alexander C Ford
Gastroenterology|March 27, 2014
Diagnosing irritable bowel syndrome with a combination of biomarkers and "psychomarkers"Ruchit Sood, Alexander C Ford
Therapeutic Advances in Chronic Disease|November 2, 2013
Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndromeRuchit Sood, Alexander C Ford
Clinical and Translational Gastroenterology|October 9, 2015
Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the PastRuchit Sood, Alexander C Ford
Gastroenterology|April 30, 2015
Combining biomarkers in irritable bowel syndrome: a forward step toward making a positive diagnosis and directing therapy?Ruchit Sood, Alexander C Ford
Gastroenterology|March 26, 2017
Derivation and Validation of a Panel of Exhaled Volatile Organic Compounds in Differentiating Irritable Bowel Syndrome From HealthRuchit Sood, Alexander C Ford
Pageof 4